Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9105 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Lauren Gresham und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mohs Surgery, Basal Cell Carcinoma, Hedgehog Proteins, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Gresham, L., Randall, G., & Tate, J. A. (2025). Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9105
Vancouver
Gresham L, Randall G, Tate JA. Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9105
BibTeX
@article{Gresham2025,
author = {Gresham, Lauren and Randall, Grant and Tate, Jesalyn A},
title = {Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9105}
}
EUVIMED